Back to search

Article

High-level clarithromycin resistance: a metabolic vulnerability exploited by bismuth in <i>Helicobacter pylori</i>

2026-05-01

Abstract excerpt

<h4>Background & Aims</h4> Clarithromycin (CLA) resistance severely compromises the efficacy of triple therapy (TT) against Helicobacter pylori ( H. pylori ). Bismuth-based regimens exhibit greater efficacy against CLA-resistant H. pylori than against strains resistant to other antibiotics, suggesting a resistance-specific vulnerability rather than broad antimicrobial activity. The mechanistic basis for this s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d8ce1100-f652-5899-86f5-9d661f888892
DOI
10.64898/2026.04.29.26351907
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High-level clarithromycin resistance: a metabolic vulnerability exploited by bismuth in <i>Helicobacter pylori</i>DOI 10.64898/2026.04.29.26351907
Select a neighboring publication to make it the new centre.